按产品类型（免疫球蛋白、凝血因子浓缩物、白蛋白、蛋白酶抑制剂和其他产品）、应用（神经病学、免疫学、血液学、重症监护、肺病学、血液肿瘤学、风湿病学和其他）、加工技术（离子交换色谱、亲和色谱、冷冻保存、超滤和微滤）、模式（现代血浆分馏和传统血浆分馏）、最终用户（医院和诊所、临床研究实验室学术机构等）、分销渠道（直接招标、第三方分销等）、国家（中国、日本、韩国、澳大利亚、印度、马来西亚、泰国、新加坡和亚太地区其他地区）行业趋势和预测到 2028 年。
市场分析与洞察：亚太血浆分离市场
预计亚太血浆分馏市场将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析称，在 2021 年至 2028 年的预测期内，该市场的复合年增长率为 7.5%，预计到 2028 年将达到 71.118 亿美元。
血浆是一种血液成分，通过血浆置换从全血中提取，用于各种治疗和医疗应用。人血浆是多种不同蛋白质的来源，但只有少数蛋白质可用于生产治疗性血浆产品。从血浆中分离、提取和纯化这些蛋白质的过程称为分馏过程。从血浆中提取的蛋白质主要分为免疫球蛋白、凝血因子浓缩物、白蛋白、蛋白酶抑制剂等类别
亚太血浆分离市场正在增长，原因是全球呼吸系统疾病增加、患有血液相关疾病的老龄人口增加以及免疫球蛋白的使用增加等因素。需要使用血浆疗法或血浆衍生物的罕见疾病的增加也是市场增长的主要因素。研发投资的增加也使亚太血浆分离市场蓬勃发展。
这份血浆分馏市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息，分析了新兴收入领域、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和市场情景，请联系我们获取分析师简报，我们的团队将帮助您创建收入影响解决方案，以实现您的预期目标。
亚太血浆分离市场范围和市场规模
Asia- Pacific Plasma Fractionation Market, By product type (immunoglobulins, coagulation factor concentrate, albumin, protease inhibitors and other products.), application (neurology, immunology, hematology, critical care, pulmonology, hemato- oncology, rheumatology, and others), processing technology (Ion- exchange chromatography , affinity chromatography, cryopreservation, ultrafiltration, and microfiltration), mode(modern plasma fraction and traditional plasma fractionation), End user (Hospitals & clinics, clinical research laboratories academic institutions and others), Distribution channel (into direct tenders, third party distribution, and others). The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets. On the basis of product type, the plasma fractionation market is segmented into immunoglobulins, coagulation factor concentrate, albumin, protease inhibitors, and other products. Further, the Immunoglobulins have been segmented further into intravenous immunoglobulins, subcutaneous immunoglonbulins, and others. Coagulation factor concentrates are further subsegmented into factor VIII, Factor CI, Von willebrand factor, Prothrombin complex concentrate, fibrinogen concentrates, and factor XII. In 2021, immunoglobulin has the largest market share owing to the factors such as the high number of health benefits associated with immunomodulatory actions.
- On the basis of application, the plasma fractionation market is segmented into neurology, immunology, hematology, critical care, pulmonology, hemato- oncology, rheumatology and others. In 2021, Immunology has the largest market share owing to the factors such as increasing usage of plasma proteins in the treatment of immune deficiencies.
- On the basis of processing technology , the plasma fractionation market is segmented into Ion- exchange chromatography , affinity chromatography, cryopreservation, ultrafiltration and microfiltration. In 2021, Ion- exchange chromatography has the largest market share owing to the factor such as the high purification capability using ions by removing inorganic substances.
- On the basis of mode, the plasma fractionation market is segmented into modern plasma fraction and traditional plasma fractionation. In 2021, modern plasma fractions has the largest market share owing to the factors such as the employing the state of art equipment and production facilities for the plasma fractionation process.
- On the basis of End User, the plasma fractionation market is segmented into Hospitals & clinics, clinical research laboratories academic institutions and others. In 2021, hospitals & clinics has the largest market share due to improving infrastructure and health care facilities provided by hospitals, along with increasing off- label use of plasma fractionated products in hospitals to treat various diseases..
- On the basis of Distribution channel, the plasma fractionation market is segmented into direct tenders, third party distribution and others . In 2021, direct tenders has the largest market share due to. Increasing distribution through direct tenders from the manufacturers to the health care workers.
Asia- Pacific Plasma Fractionation Market: Country Level Analysis
Asia- Pacific Plasma Fractionation Market is analysed and market size information is provided by country, Type (Bioinsecticides, Biofungisides, Bionematicides, Bioherbicides and Others), Source (Microbials, Biochemical and Insects), Form (Dry and Liquid), Application (Foliar Application, Fertigation, Soil Treatment, Seed Treatment and Other), Category (Agriculture and Horticulture) and Crops as referenced above.
The countries covered in the Asia- Pacific Plasma Fractionation Market report are China, Japan, South Korea, Australia, India, Malaysia, and others
China is dominating in the Asia- Pacific Plasma Fractionation Market with the highest CAGR as the region has more awareness about the extensive benefits of the plasma.
Japan is dominating in the Asia- Pacific Plasma Fractionation market due to increase in the demand for Plasma Fractionation and growing concern over the human health.
South Korea is dominating the market with the highest share due to the geriatric population and immune deficiency diseases.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia- Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Rising Demand of Plasma Fractionation in Agriculture
Asia- Pacific Plasma Fractionation Market also provides you with detailed market analysis for every country growth in the industry with sales, components sales, impact of technological development in Plasma Fractionation, and changes in regulatory scenarios with their support for the Plasma Fractionation Product market. The data is available for historic period 2012-2018.
Competitive Landscape and Asia- Pacific Plasma Fractionation Market Share Analysis
亚太血浆分馏市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、印度业务、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对亚太血浆分馏市场的关注有关。
血浆分馏市场的一些主要参与者包括 SL plasma、Grifols SA、Octapharma、Kendrion SPA、BPL Inc、Sanquin、Biotest AG、LFB SA、日本血液制品组织、中国生物制品控股有限公司、Green Cross corp、上海莱士、武田药品工业有限公司、Bioproducts Laboratory Ltd、Novasep Inc、Pall corporation、Kabafusion、四川远大蜀阳制药有限公司、Bharat Serums and Vaccines Limited、SK plasma、Centurion pharma、Ntas biopharmaceuticals、Merck KgAa、Boccard 和 ADMA biologics。
全球各地的公司也推出了许多产品，这也加速了亚太血浆分馏市场的增长。
例如，
- 2020 年 4 月，Grifols 在血浆分馏市场推出了 3 毫升瓶装 Hyper RAB，这是一种狂犬病免疫球蛋白，可帮助治疗世界各地的狂犬病病例。
市场参与者的合作、合资和其他策略正在扩大公司在血浆分馏市场的影响力，这也为组织的增长速度带来了益处。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA-PACIFIC PLASMA FRACTIONATION MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET APPLICATION COVERAGE GRID
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PRODUCTION FACILITIES FOR BLOOD PLASMA:
4.2 SUPPLIERS OF PROCESS LINES FOR PLASMA FRACTIONATION
4.2.1 RAW MATERIAL PROCUREMENT
4.2.2 MANUFACTURING
4.2.3 MARKETING & DISTRIBUTION
4.2.4 END-USERS
5 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: REGULATORY
5.1 THE U.S.
5.2 INDIA
5.3 EUROPE
5.4 BRAZIL
5.5 SOUTH AFRICA
6 MARKET OVERVIEW
6.1 3.1 DRIVERS
6.1.1 3.1.1 INCREASE IN RARE DISEASES THAT REQUIRES USE OF PLASMA THERAPY OR PLASMA DERIVATIVE
6.1.2 RISE IN RESPIRATORY DISEASES ACROSS THE WORLD
6.1.3 INCREASE IN AGING POPULATION WITH BLOOD-RELATED AILMENTS
6.1.4 INCREASE USAGE OF IMMUNOGLOBULIN
6.2 RESTRAINTS
6.2.1 GROWING USAGE OF RECOMBINANT PROTEIN PRODUCTS
6.2.2 STRINGENT GOVERNMENT REGULATIONS REGARDING PLASMA THERAPY
6.2.3 RISK OF QUALITY AND SAFETY
6.3 OPPORTUNITIES
6.3.1 INCREASE IN PLASMA COLLECTION CENTRES
6.3.2 UNHEALTHY LIFESTYLE POSSESS SERIOUS INFLAMMATION RISK
6.3.3 ADVANCEMENT IN TECHNOLOGIES
6.4 CHALLENGES
6.4.1 SHORTAGE OF PLASMA PROTEINS
6.4.2 HIGH COST OF PLASMA THERAPY
7 IMPACT OF COVID-19 ON THE ASIA-PACIFIC PLASMA FRACTIONATION MARKET
7.1 IMPACT ON PRICE
7.2 IMPACT ON DEMAND
7.3 IMPACT ON SUPPLY CHAIN
7.4 STRATEGIC DECISIONS FOR MANUFACTURERS
7.5 CONCLUSION
8 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 IMMUNOGLOBULINS
8.2.1 INTRAVENOUS IMMUNOGLOBULINS
8.2.2 SUBCUTANEOUS IMMUNOGLOBULINS
8.2.3 OTHER IMMUNOGLOBULINS
8.3 COAGULATION FACTOR CONCENTRATES
8.3.1 FACTOR IX
8.3.2 FACTOR VIII
8.3.3 FIBRINOGEN CONCENTRATES
8.3.4 PROTHROMBIN COMPLEX CONCENTRATE
8.3.5 VON WILLEBRAND FACTOR
8.3.6 FACTOR XIII
8.4 ALBUMIN
8.5 PROTEASE INHIBITORS
8.6 OTHER PRODUCTS
9 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 IMMUNOLOGY
9.3 HAEMATOLOGY
9.4 CRITICAL CARE
9.5 NEUROLOGY
9.6 PULMONOLOGY
9.7 HAEMATO-ONCOLOGY
9.8 RHEUMATOLOGY
9.9 OTHER APPLICATION
10 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY
10.1 OVERVIEW
10.2 ION-EXCHANGE CHROMATOGRAPHY
10.3 AFFINITY CHROMATOGRAPHY
10.4 ULTRAFILTRATION
10.5 MICROFILTRATION
10.6 CRYOPRECIPITATION
11 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY MODE
11.1 OVERVIEW
11.2 MODERN PLASMA FRACTIONATION
11.3 TRADITIONAL PLASMA FRACTIONATION
12 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITALS & CLINICS
12.3 CLINICAL RESEARCH LABORATORIES
12.4 ACADEMIC INSTITUTES
12.5 OTHERS
13 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDERS
13.3 THIRD PARTY DISTRIBUTION
13.4 OTHERS
14 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY REGION
14.1 ASIA-PACIFIC
14.1.1 CHINA
14.1.2 JAPAN
14.1.3 SOUTH KOREA
14.1.4 AUSTRALIA
14.1.5 INDIA
14.1.6 MALAYSIA
14.1.7 THAILAND
14.1.8 SINGAPORE
14.1.9 PHILIPPINES
14.1.10 INDONESIA
14.1.11 REST OF ASIA-PACIFIC
15 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 CSL PLASMA
17.1.1 COMPANY SNAPSHOT
17.1.2 COMPANY SHARE ANALYSIS
17.1.3 PRODUCT PORTFOLIO
17.1.4 RECENT DEVELOPMENTS
17.2 GRIFOLS, S.A.
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 COMPANY SHARE ANALYSIS
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENTS
17.3 OCTAPHARMA AG
17.3.1 COMPANY SNAPSHOT
17.3.2 COMPANY SHARE ANALYSIS
17.3.3 PRODUCT PORTFOLIO
17.3.4 RECENT DEVELOPMENTS
17.4 KENDRION S.P.A
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 COMPANY SHARE ANALYSIS
17.4.4 PRODUCT PORTFOLIO
17.4.5 RECENT DEVELOPMENTS
17.5 TAKEDA PHARMACEUTICAL COMPANY LIMITED
17.5.1 COMPANY SNAPSHOT
17.5.2 REVENUE ANALYSIS
17.5.3 PRODUCT PORTFOLIO
17.5.4 RECENT DEVELOPMENTS
17.6 BAXTER
17.6.1 COMPANY SNAPSHOT
17.6.2 REVENUE ANALYSIS
17.6.3 PRODUCT PORTFOLIO
17.6.4 RECENT DEVELOPMENT
17.7 ADMA BIOLOGICS INC.
17.7.1 COMPANY SNAPSHOT
17.7.2 REVENUE ANALYSIS
17.7.3 PRODUCT PORTFOLIO
17.7.4 RECENT DEVELOPMENT
17.8 BHARAT SERUMS AND VACCINES LIMITED (BSV)
17.8.1 COMPANY SNAPSHOT
17.8.2 PRODUCT PORTFOLIO
17.8.3 RECENT DEVELOPMENT
17.9 BIO PRODUCTS LABORATORY LTD.
17.9.1 COMPANY SNAPSHOT
17.9.2 PRODUCT PORTFOLIO
17.9.3 RECENT DEVELOPMENT
17.1 BIOTEST AG
17.10.1 COMPANY SNAPSHOT
17.10.2 REVENUE ANALYSIS
17.10.3 PRODUCT PORTFOLIO
17.10.4 RECENT DEVELOPMENTS
17.11 BOCCARD
17.11.1 COMPANY SNAPSHOT
17.11.2 PRODUCT PORTFOLIO
17.11.3 RECENT DEVELOPMENT
17.12 CENTURION İLAÇ SANAYI VE TICARET A.Ş.
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENT
17.13 CHINA BIOLOGIC PRODUCTS HOLDINGS, INC.
17.13.1 COMPANY SNAPSHOT
17.13.2 PRODUCT PORTFOLIO
17.13.3 RECENT DEVELOPMENTS
17.14 GREEN CROSS CORP.
17.14.1 COMPANY SNAPSHOT
17.14.2 REVENUE ANALYSIS
17.14.3 PRODUCT PORTFOLIO
17.14.4 RECENT DEVELOPMENTS
17.15 INTAS PHARMACEUTICAL LTD.
17.15.1 COMPANY SNAPSHOT
17.15.2 PRODUCT PORTFOLIO
17.15.3 RECENT DEVELOPMENT
17.16 JAPAN BLOOD PRODUCTS ORGANIZATION
17.16.1 COMPANY SNAPSHOT
17.16.2 PRODUCT PORTFOLIO
17.16.3 RECENT DEVELOPMENT
17.17 KABAFUSION
17.17.1 COMPANY SNAPSHOT
17.17.2 PRODUCT PORTFOLIO
17.17.3 RECENT DEVELOPMENTS
17.18 LFB SA
17.18.1 COMPANY SNAPSHOT
17.18.2 PRODUCT PORTFOLIO
17.18.3 RECENT DEVELOPMENTS
17.19 MERCK KGAA
17.19.1 COMPANY SNAPSHOT
17.19.2 REVENUE ANALYSIS
17.19.3 PRODUCT PORTFOLIO
17.19.4 RECENT DEVELOPMENT
17.2 NOVASEP HOLDING SAS
17.20.1 COMPANY SNAPSHOT
17.20.2 PRODUCT PORTFOLIO
17.20.3 RECENT DEVELOPMENTS
17.21 PALL CORPORATION
17.21.1 COMPANY SNAPSHOT
17.21.2 PRODUCT PORTFOLIO
17.21.3 RECENT DEVELOPMENT
17.22 SANQUIN
17.22.1 COMPANY SNAPSHOT
17.22.2 REVENUE ANALYSIS
17.22.3 PRODUCT PORTFOLIO
17.22.4 RECENT DEVELOPMENT
17.23 SHANGHAI RAAS
17.23.1 COMPANY SNAPSHOT
17.23.2 REVENUE ANALYSIS
17.23.3 PRODUCT PORTFOLIO
17.23.4 RECENT DEVELOPMENT
17.24 SICHUAN YUANDA SHUYANG PHARMACEUTICAL CO., LTD
17.24.1 COMPANY SNAPSHOT
17.24.2 PRODUCT PORTFOLIO
17.24.3 RECENT DEVELOPMENTS
17.25 SK PLASMA
17.25.1 COMPANY SNAPSHOT
17.25.2 PRODUCT PORTFOLIO
17.25.3 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
表格列表
TABLE 1 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 2 ASIA-PACIFIC IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 3 ASIA-PACIFIC IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 4 ASIA-PACIFIC COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 ASIA-PACIFIC COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 6 ASIA-PACIFIC ALBUMIN IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 ASIA-PACIFIC PROTEASE INHIBITORS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 ASIA-PACIFIC OTHER PRODUCTS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, APPLICATION, 2019-2028 (USD MILLION)
TABLE 10 ASIA-PACIFIC IMMUNOLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 ASIA-PACIFIC HAEMATOLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 ASIA-PACIFIC CRITICAL CARE IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 ASIA-PACIFIC NEUROLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 ASIA-PACIFIC PULMONOLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 ASIA-PACIFIC HAEMATO-ONCOLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 ASIA-PACIFIC RHEUMATOLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 ASIA-PACIFIC OTHER APPLICATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 19 ASIA-PACIFIC ION-EXCHANGE CHROMATOGRAPHY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 ASIA-PACIFIC AFFINITY CHROMATOGRAPHY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 ASIA-PACIFIC ULTRAFILTRATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 ASIA-PACIFIC MICROFILTRATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 ASIA-PACIFIC CRYOPRECIPITATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, MODE, 2019-2028 (USD MILLION)
TABLE 25 ASIA-PACIFIC MODERN PLASMA FRACTIONATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 ASIA-PACIFIC TRADITIONAL PLASMA FRACTIONATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, END USER, 2019-2028 (USD MILLION)
TABLE 28 ASIA-PACIFIC HOSPITALS & CLINICS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 ASIA-PACIFIC CLINICAL RESEARCH LABORATORIES IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 ASIA-PACIFIC ACADEMIC INSTITUTES IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 ASIA-PACIFIC OTHERS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 33 ASIA-PACIFIC DIRECT TENDERS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 34 ASIA-PACIFIC THIRD PARTY DISTRIBUTION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 35 ASIA-PACIFIC OTHERS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 36 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 37 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 38 ASIA-PACIFIC IMMUNOGLOBINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 39 ASIA-PACIFIC COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 40 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 41 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 42 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 43 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 44 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 45 CHINA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 46 CHINA IMMUNOGLOBINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 47 CHINA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 48 CHINA PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 49 CHINA PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 50 CHINA PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 51 CHINA PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 52 CHINA PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 53 JAPAN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 54 JAPAN IMMUNOGLOBINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 55 JAPAN COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 56 JAPAN PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 57 JAPAN PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 58 JAPAN PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 59 JAPAN PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 60 JAPAN PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 61 SOUTH KOREA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 62 SOUTH KOREA IMMUNOGLOBINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 63 SOUTH KOREA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 64 SOUTH KOREA PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 65 SOUTH KOREA PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 66 SOUTH KOREA PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 67 SOUTH KOREA PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 68 SOUTH KOREA PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 69 AUSTRALIA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 70 AUSTRALIA IMMUNOGLOBINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 71 AUSTRALIA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 72 AUSTRALIA PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 73 AUSTRALIA PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 74 AUSTRALIA PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 75 AUSTRALIA PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 76 AUSTRALIA PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 77 INDIA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 78 INDIA IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 79 INDIA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 80 INDIA PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 81 INDIA PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 82 INDIA PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 83 INDIA PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 84 INDIA PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 85 MALAYSIA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 86 MALAYSIA IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 87 MALAYSIA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 88 MALAYSIA PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 89 MALAYSIA PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 90 MALAYSIA PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 91 MALAYSIA PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 92 MALAYSIA PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 93 THAILAND PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 94 THAILAND IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 95 THAILAND COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 96 THAILAND PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 97 THAILAND PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 98 THAILAND PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 99 THAILAND PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 100 THAILAND PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 101 SINGAPORE PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 102 SINGAPORE IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 103 SINGAPORE COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 104 SINGAPORE PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 105 SINGAPORE PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 106 SINGAPORE PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 107 SINGAPORE PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 108 SINGAPORE PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 109 PHILIPPINES PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 110 PHILIPPINES IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 111 PHILIPPINES COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 112 PHILIPPINES PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 113 PHILIPPINES PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 114 PHILIPPINES PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 115 PHILIPPINES PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 116 PHILIPPINES PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 117 INDONESIA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 118 INDONESIA IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 119 INDONESIA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 120 INDONESIA PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 121 INDONESIA PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 122 INDONESIA PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 123 INDONESIA PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 124 INDONESIA PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 125 REST OF ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
图片列表
FIGURE 1 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: SEGMENTATION
FIGURE 2 ASIA-PACIFIC PLASMA FRACTIONATION MARKET : DATA TRIANGULATION
FIGURE 3 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC PLASMA FRACTIONATION MARKET : COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC PLASMA FRACTIONATION MARKET : INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: DBMR MARKET POSITION GRID
FIGURE 8 ASIA-PACIFIC PLASMA FRACTIONATION MARKET : VENDOR SHARE ANALYSIS
FIGURE 9 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 10 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: SEGMENTATION
FIGURE 11 INCREASE IN RARE DISEASES THAT REQUIRES USE OF PLASMA THERAPY OR PLASMA DERIVATIVE IS EXPECTED TO DRIVE THE GROWTH OF THE ASIA-PACIFIC PLASMA FRACTIONATION MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 IMMUNOGLOBULINS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC PLASMA FRACTIONATION MARKET IN 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF ASIA-PACIFIC PLASMA FRACTIONATION MARKET
FIGURE 14 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY PRODUCT TYPE, 2020
FIGURE 15 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY PRODUCT TYPE, 2020-2028 (USD MILLION)
FIGURE 16 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY PRODUCT TYPE, CAGR (2020-2028)
FIGURE 17 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 18 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY APPLICATION, 2020
FIGURE 19 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY APPLICATION, 2020-2028 (USD MILLION)
FIGURE 20 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY APPLICATION, CAGR (2020-2028)
FIGURE 21 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 22 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY PROCESSING TECHNOLOGY, 2020
FIGURE 23 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY PROCESSING TECHNOLOGY, 2020-2028 (USD MILLION)
FIGURE 24 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY PROCESSING TECHNOLOGY, CAGR (2020-2028)
FIGURE 25 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY PROCESSING TECHNOLOGY, LIFELINE CURVE
FIGURE 26 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY MODE, 2020
FIGURE 27 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY MODE, 2020-2028 (USD MILLION)
FIGURE 28 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY MODE, CAGR (2020-2028)
FIGURE 29 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY MODE, LIFELINE CURVE
FIGURE 30 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY END USER, 2020
FIGURE 31 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY END USER, 2020-2028 (USD MILLION)
FIGURE 32 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY END USER, CAGR (2020-2028)
FIGURE 33 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY END USER, LIFELINE CURVE
FIGURE 34 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 35 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY DISTRIBUTION CHANNEL, 2020-2028 (USD MILLION)
FIGURE 36 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY DISTRIBUTION CHANNEL, CAGR (2020-2028)
FIGURE 37 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 38 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: SNAPSHOT (2020)
FIGURE 39 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY COUNTRY (2020)
FIGURE 40 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY COUNTRY (2021 & 2028)
FIGURE 41 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY COUNTRY (2020 & 2028)
FIGURE 42 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY PRODUCT TYPE (2021 & 2028)
FIGURE 43 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: COMPANY SHARE 2020 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
